Em recrutamento
FASE
Número Europeu 2023-507914-28-00
DS6000-109 REJOICE-Ovarian01
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Detalhes
Destaques